Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $531.21 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $282.96 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $107.92 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $80.71 | 1 | $0 (2017) |
| AbbVie, Inc. | $59.62 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $107.92 | 1 | AstraZeneca Pharmaceuticals LP ($107.92) |
| 2018 | $77.30 | 1 | Janssen Pharmaceuticals, Inc ($77.30) |
| 2017 | $345.99 | 7 | Janssen Pharmaceuticals, Inc ($205.66) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $107.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $77.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $117.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/11/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $88.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Immunology | ||||||
| 05/09/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $80.71 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Immunology | ||||||
| 03/13/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Immunology | ||||||
| 02/24/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Immunology | ||||||
About Dr. Paul Weisberg, M.D
Dr. Paul Weisberg, M.D is a Gastroenterology healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679537351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Weisberg, M.D has received a total of $531.21 in payments from pharmaceutical and medical device companies, with $107.92 received in 2021. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($531.21).
Practice Information
- Specialty Gastroenterology
- Location Bala Cynwyd, PA
- Active Since 04/12/2006
- Last Updated 09/06/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1679537351
Products in Payments
- XARELTO (Drug) $194.40
- LOKELMA (Drug) $107.92
- INVOKANA (Drug) $88.56
- BELSOMRA (Drug) $80.71
- Humira (Biological) $59.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bala Cynwyd
Alexander Harmatz, M.d, M.D
Gastroenterology — Payments: $18,624
Anthony Rosa, M.d, M.D
Gastroenterology — Payments: $12,302
Raynard Cheung, M.d, M.D
Gastroenterology — Payments: $11,456
Jeffrey Pilchman, M.d, M.D
Gastroenterology — Payments: $6,611
Gregory Schapiro, M.d, M.D
Gastroenterology — Payments: $5,597
Jenifer Lehrer, M.d, M.D
Gastroenterology — Payments: $5,549